Latest Trials Latest NewsFAQ

WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer

Phase 2

Withdrawn

Conditions: Brain Metastases
Non-small Cell Lung Cancer

Interventions: Other: Placebo
Drug: Lucanthone

First Posted Date: 2013-12-18

Last Posted Date: 2018-07-05

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT02014545

Locations: 🇺🇸
Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States

Bioelectrical Impedance Phase Angle in Predicting Treatment Outcome in Patients With Extensive Stage Small Cell Lung Cancer Receiving First-Line Chemotherapy

Not Applicable

Terminated

Conditions: Extensive Stage Small Cell Lung Cancer

Interventions: Procedure: bioelectric impedance analysis

First Posted Date: 2013-12-13

Last Posted Date: 2018-07-05

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 1

Registration Number: NCT02011087

Locations: 🇺🇸
Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States

ACTH Treatment of APOL1- Associated Nephropathy

Not Applicable

Withdrawn

Conditions: Kidney Disease

Interventions: Drug: Acthar

First Posted Date: 2013-12-10

Last Posted Date: 2017-11-07

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT02006849

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

A Randomized, Controlled Trial of Inspiratory Muscle Training (IMT)in the ICU and CCU

Not Applicable

Completed

Conditions: Critically Ill
Respiratory Failure

Interventions: Device: Inspiratory Muscle Trainer

First Posted Date: 2013-12-06

Last Posted Date: 2018-09-07

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 7

Registration Number: NCT02003053

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia

Completed

Conditions: Leukemia, Myelogenous, Acute

First Posted Date: 2013-12-03

Last Posted Date: 2022-04-21

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 6

Registration Number: NCT01999556

Locations: 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States

The Role of Estrogen in Luteinizing Hormone Surge and Ovulation

Phase 4

Completed

Conditions: Ovulation Disorder
Ovarian Cysts

Interventions: Drug: Letrozole

First Posted Date: 2013-12-03

Last Posted Date: 2022-04-22

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 10

Registration Number: NCT01999569

Locations: 🇺🇸
Women's Institute at Carolinas Medical Center, Charlotte, North Carolina, United States

Persistent Pain After CS Delivery

Completed

Conditions: Persistent Pain After Delivery

First Posted Date: 2013-11-27

Last Posted Date: 2018-08-13

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 575

Registration Number: NCT01996592

Locations: 🇺🇸
Forsyth Medical Center, Winston-Salem, North Carolina, United States

Efficacy of Spinal Oxytocin in Healthy Volunteers

Phase 2

Terminated

Conditions: Healthy Volunteer Study

Interventions: Drug: Placebo
Drug: Oxytocin 150 mcg
Drug: Oxytocin 15 mcg

First Posted Date: 2013-11-27

Last Posted Date: 2023-09-14

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 20

Registration Number: NCT01996605

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

Phase 2

Completed

Conditions: Breast Cancer
Lymphoma

Interventions: Drug: Atorvastatin
Drug: Placebo

First Posted Date: 2013-11-20

Last Posted Date: 2022-01-04

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 279

Registration Number: NCT01988571

Locations: 🇺🇸
Mission Hospital, Asheville, North Carolina, United States
🇺🇸
Hope Women's Cancer Centers-Asheville, Asheville, North Carolina, United States
🇺🇸
Novant Health Cancer Specialists-Matthews, Matthews, North Carolina, United States

and more 48 locations

CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer

Not Applicable

Completed

Conditions: Prostate Adenocarcinoma

Interventions: Radiation: CyberKnife
Other: Androgen Deprivation Therapy (ADT)
Radiation: Intensity Modulated radiation therapy (IMRT)

First Posted Date: 2013-11-15

Last Posted Date: 2024-10-03

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 83

Registration Number: NCT01985828

Locations: 🇺🇸
Advocate Lutheran General Hospital, Park Ridge, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy